Translational Projects Overview
The basic, clinical, and population research proposed within the Yale SPORE in Lung Cancer aims to improve the overall survival rate of lung cancer patients through the development of novel therapeutics and personal prevention strategies.
Currently, these aims will be accomplished through four on-going projects that are part of the Yale SPORE in Lung Cancer:
The inability of tumor infiltrating lymphocytes (TILs) to target and kill tumor cells is a major hurdle in treating many malignancies.
Targeted therapies have completely transformed the landscape for diagnosis and treatment of metastatic lung cancer.